Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

NHA000184

Type of data
GWAS for 9,826 AF patients and 140,446 controls from BBJ 1st cohort
GWAS meta-analysis for 77,690 AF patients and 1,167,040 controls
Access criteria
Unrestricted-access
Total data volume
547 MB
File formats
  • TXT
  • ZIP
Research
hum0014
Date published
2023-04-05
Date modified
2023-04-05
Secondary ID
hum0014.v29.AF.v1

Unrestricted-access files linked to this dataset

Download the URL list
FileLabelSizeCopy URL
hum0014.v29.AF.v1.zip547 MB
hum0014.v29_README.txtDictionary file3.1 KB

Analysis method

Genotyping by array

Materials and participants
77,690 atrial fibrillation patients and 1,167,040 controls
BBJ: 9,826 atrial fibrillation patients and 140,446 controls
European: 60,620 atrial fibrillation patients and 970,216 controls
FinnGen: 7,244 atrial fibrillation patients and 56,378 controls
  • Health status
    Mixed
  • Subject count
    1,244,730 (Individual)
  • Population
    European, Finnish, Japanese
Disease
atrial fibrillation patients (I48)
Sample description
DNA extracted from peripheral blood cells
European GWAS: http://csg.sph.umich.edu/willer/public/afib2018
FinnGen GWAS: https://www.finngen.fi/en
  • Tissue
    Peripheral blood
  • Tumor / normal
    Normal
Sample provider
N/A
Experimental method
Genotyping by array
Target
N/A
Reagent kit
HumanExome BeadChip Kit
HumanOmniExpress BeadChip Kit
HumanOmniExpressExome BeadChip Kit
Platform
Illumina HumanExome
Illumina HumanOmniExpress
Illumina HumanOmniExpressExome
QC and filtering
BBJ GWAS: variants with imputation quality (Rsq) < 0.3 or MAF < 0.001 were excluded
meta-analysis: variants with MAF < 1% were excluded
Imputation
minimac [imputation (1000 genomes Phase I v3)]
Analysis method
GenCall software (GenomeStudio), minimac [imputation (1000 genomes Phase I v3)]
Variant count
BBJ GWAS: 16,817,144 SNPs
Meta-analysis GWAS: 5,158,449 SNPs
Processed data type
GWAS summary statistics
Polygenic risk score
Data use policy
NBDC data sharing policy (JGAP000001)